1. Hu Y, Zhou P, Deng K, Zhou Y, Hu K. Targeting the gut microbiota: a new strategy for colorectal cancer treatment. J Transl Med. 2024;22(1):915. [
DOI:10.1186/s12967-024-05671-02.]
2. Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol. 2018;7:1204. [
DOI:10.3389/fmicb.2016.01204.]
3. Kim H-J, An J, Ha E-M. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells. J Microbiol. 2022;60(1):100–17. [
DOI:10.1007/s12275-022-1495-1.]
4. Yue Y-C, Yang B-Y, Lu J, Zhang S-W, Liu L, Nassar K, et al. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway. Microb Cell Fact. 2020;19:1–12. [
DOI:10.1186/s12934-020-01424-2.]
5. Zinatizadeh N, Khalili F, Fallah P, Farid M, Geravand M, Yaslianifard S. Potential preventive effect of Lactobacillus acidophilus and Lactobacillus plantarum in patients with polyps or colorectal cancer. Arq Gastroenterol. 2018;55:407–11. [
DOI:10.1590/S0004-2803.201800000-93.]
6. Zaharuddin L, Mokhtar NM, Muhammad Nawawi KN, Raja Ali RA. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol. 2019;19:1–8. [
DOI:10.1186/s12876-019-1047-4.]
7. Wu Y, Zhuang J, Zhang Q, Zhao X, Chen G, Han S, et al. Aging characteristics of colorectal cancer based on gut microbiota. Cancer Medicine. 2023;12(17):17822–34. [
DOI:10.1002/cam4.6327.]
8. Khodaverdi N, Zeighami H, Jalilvand A, Haghi F, Hesami N. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients. BMC cancer. 2021;21(1):1353. [
DOI:10.1186/s12885-021-09141-z.]
9. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2018;19(11):1423–37. [
DOI:10.1038/nm.3394.]
10. Gajewski TF, Schreiber H, Fu Y-X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2018;14(10):1014–22. [
DOI:10.1038/ni.2703.]
11. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2019;8(3):171–84. [
DOI:10.1038/nrmicro2297.]
12. van Bokhorst-van de Veen H, Abee T, Tempelaars M, Bron PA, Kleerebezem M, Marco ML. Short-and long-term adaptation to ethanol stress and its cross-protective consequences in Lactobacillus plantarum. Appl Environ Microbiol. 2019;77(15):5247–56. [
DOI:10.1128/AEM.01857-10.]
13. Garrett WS. Cancer and the microbiota. Science. 2019;348(6230):80–6. [
DOI:10.1126/science.aaa4972.]
14. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2018;65(12):1973–80. [
]
15. O’Toole PW, Jeffery IB. Microbiome–health interactions in older people. Cell Mol Life Sci. 2018;75:119–2. [
DOI:10.1136/gutjnl-2015-310101.]
16. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2018;339(6123):1084–8. [
DOI:10.1126/science.1233521.]
17. Kwon H-K, Lee C-G, So J-S, Chae C-S, Hwang J-S, Sahoo A, et al. Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A. 2019;107(5):2159–64. [
DOI:10.1073/pnas.0904055107.]
18. Liu Y, Alookaran JJ, Rhoads JM. Probiotics in autoimmune and inflammatory disorders. Nutrients. 2018;10(10):1537. [
DOI:10.3390/nu10101537.]
19. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients23. Am J Clin Nutr. 2019;85(2):488–96. [
DOI:10.1093/ajcn/85.2.488..]